Premium
Is It Possible for FDA Regulatory Scientists and Industry Scientists to Work Together? 2011 William B. Abrams Lecture 4 May 2011 Silver Spring, Maryland
Author(s) -
Woosley R L
Publication year - 2012
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2011.304
Subject(s) - food and drug administration , regulatory agency , regulatory science , clinical pharmacology , agency (philosophy) , engineering ethics , pharmaceutical industry , work (physics) , business , pharmacology , medicine , political science , engineering , public administration , sociology , mechanical engineering , social science , pathology
The US Food and Drug Administration (FDA) was established as a regulatory agency to protect the public health by ensuring that foods, medications, devices, and many other products are safe, effective, and properly labeled. William Abrams demonstrated that scientists from the pharmaceutical industry and the FDA can work together with integrity and synergy to develop scientific and educational programs, thus paving the way for more recent precompetitive collaborations between the “regulators” and the “regulated.” Clinical Pharmacology & Therapeutics (2012); 91 3, 390–392. doi: 10.1038/clpt.2011.304